Failed IVF: What to Review Before the Next Cycle

Medically reviewed on 14 May 2026 - Dr. Senai Aksoy
Failed IVF: What to Review Before the Next Cycle

Key Takeaways

A failed IVF cycle should trigger a structured review rather than automatic repetition of the same plan. The most important questions are where the cycle underperformed, whether a uterine or tubal factor was missed, and whether the next step is protocol adjustment, further testing, or simply another attempt.

Failed IVF: What to Review Before the Next Cycle

A failed IVF cycle is emotionally difficult, but it should also be clinically informative. The next step is not always to repeat the same protocol immediately. The more useful question is where the cycle underperformed and whether that problem is likely to respond to a different plan.

Start With a Structured Cycle Review

The review should cover each stage of treatment:

Sometimes one weak point is obvious. In other cases, several smaller factors combine.

Questions to Ask After a Failed Cycle

Was the Ovarian Response Appropriate?

If egg yield was much lower or higher than expected, the stimulation protocol may need adjustment. Poor response can reflect age, ovarian reserve, or protocol mismatch. Excessive response can create safety issues and may support a freeze-all approach in a later cycle.

Was Fertilization or Embryo Development Suboptimal?

Poor fertilization or weak blastocyst development can point toward sperm factors, oocyte quality, culture-related issues, or simple biological variation from one cycle to the next. When embryo development repeatedly underperforms, the laboratory record and male-factor evaluation deserve closer review.

Was a Uterine or Tubal Factor Missed?

Polyps, fibroids that distort the cavity, adhesions, congenital anomalies, adenomyosis, chronic endometritis in selected cases, or untreated hydrosalpinx can reduce implantation potential. If these have not been reviewed recently, reassessment may be reasonable before another transfer.

When More Testing Can Help

Further testing should be selective rather than routine. Depending on the history, a clinician may consider:

Not every test marketed after failed IVF improves outcomes. A more extensive workup is most useful when there is a repeating pattern, such as repeated poor embryo development, repeated failed euploid transfers, or a strong history suggesting a specific diagnosis.

When Another Attempt May Be Reasonable Without Major Changes

One failed cycle does not automatically mean something rare has been missed. In some cases, especially after transfer of an untested embryo, another attempt may be reasonable with only modest protocol refinement. Implantation is never guaranteed even when many parts of the cycle appear favorable.

When a Larger Change in Strategy Makes Sense

A more substantial change may be considered when:

This is also the point where second opinions can be useful, especially if the same cycle design has been repeated without a clear reason.

Conclusion

Failed IVF should lead to analysis, not panic. The most productive next step is a structured review of the cycle, a focused search for missed factors, and a realistic discussion about whether the next attempt

needs a minor adjustment, a major strategy change, or simply another well-timed try.

FAQ

Does one failed IVF cycle mean something is wrong?

Not always. Even a well-designed cycle can fail, especially after transfer of an untested embryo. The key is to review the cycle carefully before assuming a rare diagnosis.

What should be reviewed first after failed IVF?

Start with ovarian response, egg maturity, fertilization, embryo development, embryo quality, transfer details, and the uterine or tubal environment.

Are more tests always useful after a failed cycle?

No. Testing is most useful when the history suggests a specific problem or when a pattern repeats, such as poor embryo development or repeated failed euploid transfers.

When should the next cycle plan change?

A larger change may be reasonable when response was clearly inadequate, embryo development repeatedly underperforms, uterine or tubal pathology is present, or time-sensitive age and ovarian reserve factors are shaping the decision.

Sources

Dr. Senai Aksoy

Dr. Senai Aksoy studied and trained in France before returning to Turkey, where he was a founding member of the ICSI team at Sevgi Hospital, Ankara — the country's first ICSI centre (1994-95) — and a co-author on the first Turkish ICSI publications produced in collaboration with the Brussels Van Steirteghem group (Human Reproduction, 1996; PMID 8671323). He helped build the IVF programme at the American Hospital Istanbul and has been running his own fertility practice since 1998.

Verified profiles: PubMed ORCID LinkedIn

The content has been created by Dr. Senai Aksoy and medically approved.